Abstract
Endovascular recanalization therapy (ERT) has been a standard of care for patients with acute ischemic stroke due to large artery occlusion (LAO) within 6 hours after onset, since five landmark ERT trials conducted by 2015 demonstrated its clinical benefit. Recently, two randomized clinical trials demonstrated that ERT, even in the late time window of up to 16 hours or 24 hours after last known normal time, improved the outcome of patients who had a target mismatch, defined as either clinical-core mismatch or perfusion-core mismatch, which prompted the update of national guidelines in several countries. Accordingly, to provide evidence-based and up-to-date recommendations for ERT in patients with acute LAO in Korea, the Clinical Practice Guidelines Committee of the Korean Stroke Society decided to revise the previous Korean Clinical Practice Guidelines of Stroke for ERT. For this update, the members of the writing group were appointed by the Korean Stroke Society and the Korean Society of Interventional Neuroradiology. After thoroughly reviewing the updated evidence from two recent trials and relevant literature, the writing members revised recommendations, for which formal consensus was achieved by convening an expert panel composed of 45 experts from the participating academic societies. The current guidelines are intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT. The ultimate decision for ERT in a particular patient must be made in light of circumstances specific to that patient.
| Original language | English |
|---|---|
| Pages (from-to) | 231-240 |
| Number of pages | 10 |
| Journal | Journal of Stroke |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2019 May |
Fingerprint
All Science Journal Classification (ASJC) codes
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
Cite this
}
2019 update of the Korean clinical practice guidelines of stroke for endovascular recanalization therapy in patients with acute ischemic stroke. / Ko, Sang Bae; Park, Hong Kyun; Kim, Byung Moon; Heo, Ji Hoe; Rha, Joung Ho; Kwon, Sun U.; Kim, Jong S.; Lee, Byung Chul; Suh, Sang Hyun; Jung, Cheolkyu; Jeong, Hae Woong; Kang, Dong Hun; Bae, Hee Joon; Yoon, Byung Woo; Hong, Keun Sik.
In: Journal of Stroke, Vol. 21, No. 2, 05.2019, p. 231-240.Research output: Contribution to journal › Article
TY - JOUR
T1 - 2019 update of the Korean clinical practice guidelines of stroke for endovascular recanalization therapy in patients with acute ischemic stroke
AU - Ko, Sang Bae
AU - Park, Hong Kyun
AU - Kim, Byung Moon
AU - Heo, Ji Hoe
AU - Rha, Joung Ho
AU - Kwon, Sun U.
AU - Kim, Jong S.
AU - Lee, Byung Chul
AU - Suh, Sang Hyun
AU - Jung, Cheolkyu
AU - Jeong, Hae Woong
AU - Kang, Dong Hun
AU - Bae, Hee Joon
AU - Yoon, Byung Woo
AU - Hong, Keun Sik
PY - 2019/5
Y1 - 2019/5
N2 - Endovascular recanalization therapy (ERT) has been a standard of care for patients with acute ischemic stroke due to large artery occlusion (LAO) within 6 hours after onset, since five landmark ERT trials conducted by 2015 demonstrated its clinical benefit. Recently, two randomized clinical trials demonstrated that ERT, even in the late time window of up to 16 hours or 24 hours after last known normal time, improved the outcome of patients who had a target mismatch, defined as either clinical-core mismatch or perfusion-core mismatch, which prompted the update of national guidelines in several countries. Accordingly, to provide evidence-based and up-to-date recommendations for ERT in patients with acute LAO in Korea, the Clinical Practice Guidelines Committee of the Korean Stroke Society decided to revise the previous Korean Clinical Practice Guidelines of Stroke for ERT. For this update, the members of the writing group were appointed by the Korean Stroke Society and the Korean Society of Interventional Neuroradiology. After thoroughly reviewing the updated evidence from two recent trials and relevant literature, the writing members revised recommendations, for which formal consensus was achieved by convening an expert panel composed of 45 experts from the participating academic societies. The current guidelines are intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT. The ultimate decision for ERT in a particular patient must be made in light of circumstances specific to that patient.
AB - Endovascular recanalization therapy (ERT) has been a standard of care for patients with acute ischemic stroke due to large artery occlusion (LAO) within 6 hours after onset, since five landmark ERT trials conducted by 2015 demonstrated its clinical benefit. Recently, two randomized clinical trials demonstrated that ERT, even in the late time window of up to 16 hours or 24 hours after last known normal time, improved the outcome of patients who had a target mismatch, defined as either clinical-core mismatch or perfusion-core mismatch, which prompted the update of national guidelines in several countries. Accordingly, to provide evidence-based and up-to-date recommendations for ERT in patients with acute LAO in Korea, the Clinical Practice Guidelines Committee of the Korean Stroke Society decided to revise the previous Korean Clinical Practice Guidelines of Stroke for ERT. For this update, the members of the writing group were appointed by the Korean Stroke Society and the Korean Society of Interventional Neuroradiology. After thoroughly reviewing the updated evidence from two recent trials and relevant literature, the writing members revised recommendations, for which formal consensus was achieved by convening an expert panel composed of 45 experts from the participating academic societies. The current guidelines are intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT. The ultimate decision for ERT in a particular patient must be made in light of circumstances specific to that patient.
UR - http://www.scopus.com/inward/record.url?scp=85068596704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068596704&partnerID=8YFLogxK
U2 - 10.5853/jos.2019.00024
DO - 10.5853/jos.2019.00024
M3 - Article
AN - SCOPUS:85068596704
VL - 21
SP - 231
EP - 240
JO - Journal of Stroke
JF - Journal of Stroke
SN - 2287-6391
IS - 2
ER -